Risk of Thrombolytic Therapy for Acute Ischemic Stroke in Patients With Current Malignancy
Authors:
- Shihab MasrurSMShihab Masrur
- Abdul R. AbdullahAAAbdul R. Abdullah
- Eric E. SmithESEric E. Smith
- Renzo HidalgoRHRenzo Hidalgo
- Ahmed El-GhandourAEAhmed El-Ghandour
- Guy RordorfGRGuy Rordorf
- Lee H. SchwammLSLee H. Schwamm
- 1 March 2011
- journal article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 20 (2) , 124-130
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hospital Treatment of Patients With Ischemic Stroke or Transient Ischemic Attack Using the “Get With The Guidelines” ProgramArchives of internal medicine (1960), 2008
- Multifocal strokes as the presentation of occult lung cancerJournal of Neuro-Oncology, 2007
- Stroke risk factor, pattern and outcome in patients with cancerActa Neurologica Scandinavica, 2006
- Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patientsClinical Neurology and Neurosurgery, 2006
- Increased incidence of stroke in women with breast cancerEuropean Journal of Cancer, 2005
- Stroke in patients with cancerNeurology, 2004
- Efficacy and Safety of Reteplase for Central Venous Catheter Occlusion in Patients with CancerJournal of Vascular and Interventional Radiology, 2004
- Meta-analysis of vascular and neoplastic events associated with tamoxifenJournal of General Internal Medicine, 2003
- Cerebrovascular complications in cancer patientsNeurologic Clinics, 2003
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995